Reviva Pharmaceuticals
RVPHDeveloping therapies that seek to address unmet medical needs in the areas of central nervous system, cardiovascular, metabolic, and inflammatory diseases.
RVPH · Stock Price
USD 0.83-20.97 (-96.19%)
Market Cap: $10.4M
Historical price data
About
Developing therapies that seek to address unmet medical needs in the areas of central nervous system, cardiovascular, metabolic, and inflammatory diseases.
Small Molecules
Pipeline
22 drugs in pipeline1 in Phase 3
| Drug | Indication | Stage | Watch |
|---|---|---|---|
| Brilaroxazine | Schizophrenia | Phase 3 | |
| RP5063 + placebo + aripiprazole | Acute Schizophrenia | Phase 2 |